248 related articles for article (PubMed ID: 25769486)
1. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
Hajiabadi M; Alimohamadi M; Fahlbusch R
World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study of the clinical application of optic pathway diffusion tensor tractography in suprasellar tumor surgery: preoperative, intraoperative, and postoperative assessment.
Hajiabadi M; Samii M; Fahlbusch R
J Neurosurg; 2016 Sep; 125(3):759-65. PubMed ID: 26684774
[TBL] [Abstract][Full Text] [Related]
3. Application of diffusion tensor tractography in pediatric optic pathway glioma.
Lober RM; Guzman R; Cheshier SH; Fredrick DR; Edwards MS; Yeom KW
J Neurosurg Pediatr; 2012 Oct; 10(4):273-80. PubMed ID: 22900485
[TBL] [Abstract][Full Text] [Related]
4. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma.
Chouinard PA; Striemer CL; Ryu WH; Sperandio I; Goodale MA; Nicolle DA; Rotenberg B; Duggal N
J Neurosurg; 2012 Aug; 117(2):218-24. PubMed ID: 22680245
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
Rutland JW; Padormo F; Yim CK; Yao A; Arrighi-Allisan A; Huang KH; Lin HM; Chelnis J; Delman BN; Shrivastava RK; Balchandani P
J Neurosurg; 2019 Jan; 132(2):333-342. PubMed ID: 30660127
[TBL] [Abstract][Full Text] [Related]
6. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes.
Müslüman AM; Cansever T; Yılmaz A; Kanat A; Oba E; Çavuşoğlu H; Sirinoğlu D; Aydın Y
World Neurosurg; 2011; 76(1-2):141-8; discussion 63-6. PubMed ID: 21839965
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
Monteiro ML; Zambon BK; Cunha LP
Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
[TBL] [Abstract][Full Text] [Related]
9. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Outcomes After Endoscopic Endonasal Surgery for Large and Giant Pituitary Macroadenoma: A Retrospective Review of 39 Consecutive Patients.
Chabot JD; Chakraborty S; Imbarrato G; Dehdashti AR
World Neurosurg; 2015 Oct; 84(4):978-88. PubMed ID: 26074433
[TBL] [Abstract][Full Text] [Related]
11. Can Preoperative Diffusion Tensor Imaging Tractography Predict the Visual Outcomes of Patients with Pituitary Macroadenomas? A Prospective Pilot Study.
Mohamadzadeh O; Sadrehosseini SM; Tabari A; Ghanaati H; Zeinalizadeh M
World Neurosurg; 2023 Apr; 172():e326-e334. PubMed ID: 36640834
[TBL] [Abstract][Full Text] [Related]
12. Visual Outcome of an Endoscopic Endonasal Transsphenoidal Approach in Pituitary Macroadenomas: Quantitative Assessment with Diffusion Tensor Imaging Early and Long-Term Results.
Anik I; Anik Y; Cabuk B; Caklili M; Pirhan D; Ozturk O; Cirak M; Ceylan S
World Neurosurg; 2018 Apr; 112():e691-e701. PubMed ID: 29408649
[TBL] [Abstract][Full Text] [Related]
13. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
14. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.
Lachowicz E; Lubiński W
Doc Ophthalmol; 2018 Aug; 137(1):37-45. PubMed ID: 29968203
[TBL] [Abstract][Full Text] [Related]
16. The role of diffusion tensor tractography in the surgical treatment of pediatric optic chiasmatic gliomas.
Ge M; Li S; Wang L; Li C; Zhang J
J Neurooncol; 2015 Apr; 122(2):357-66. PubMed ID: 25617076
[TBL] [Abstract][Full Text] [Related]
17. Patterns of visual loss associated with pituitary macroadenomas.
Poon A; McNeill P; Harper A; O'Day J
Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
[TBL] [Abstract][Full Text] [Related]
18. The time course of visual field recovery and changes of retinal ganglion cells after optic chiasmal decompression.
Moon CH; Hwang SC; Ohn YH; Park TK
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7966-73. PubMed ID: 21896856
[TBL] [Abstract][Full Text] [Related]
19. DTI of the visual pathway in cerebral lesions.
Hana A; Husch A; Hana A; Boecher-Schwarz H; Hertel F
Bull Soc Sci Med Grand Duche Luxemb; 2012; (2):15-24. PubMed ID: 23362563
[TBL] [Abstract][Full Text] [Related]
20. Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes.
Agrawal D; Mahapatra AK
Surg Neurol; 2005 Jan; 63(1):42-6; discussion 46. PubMed ID: 15639521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
